EOD Prostate Pathologic Extension
This input is used for staging
Notes
**Note 1:** Only use histologic information from a radical prostatectomy and/or autopsy in this field. Information from biopsy of extraprostatic sites is coded in EOD Primary Tumor. * Code results from a transurethral resection of prostate (TURP) or simple prostatectomy in EOD Primary Tumor **Note 2:** Code 900 if there is no radical prostatectomy or autopsy performed within first course of treatment. (See also Note 7) * A radical prostatectomy is defined as Surgery of Primary Site codes 50-70 * If Surgery of primary site is 00-30, 90, then code 900 * *Note:* Surgery of primary site can be 00 if an autopsy is done **Note 3:** Limit information in this field to first course of treatment in the absence of disease progression. **Note 4:** When prostate cancer is an incidental finding during a prostatectomy for other reasons (for example, a cystoprostatectomy for bladder cancer), or an autopsy, use the appropriate code for the extent of disease found. **Note 5:** Involvement of the prostatic urethra does not alter the extension code. **Note 6:** "Frozen pelvis" is a clinical term which means tumor extends to pelvic sidewall(s). In the absence of a more detailed statement of involvement, assign this to code 700. **Note 7:** Code 950 is used when first course of treatment is active surveillance, but a radical prostatectomy is done at a later date due to disease progression or the patient changed their mind. * When code 950 is used, code the following SSDIs as X9: Gleason Patterns Pathological, Gleason Score Pathological, and Gleason Tertiary, **Note 8:** Code 999 when * Radical prostatectomy is performed, but there is no information on the extension * Surgery of Primary Site is Prostatectomy, NOS (Surgery of Primary Site is 80) * Unknown if surgery is done (Surgery of Primary Site is 99)Default
999NAACCR Item
NAACCR #3919| Code | Description | SS2018 T |
|---|---|---|
| 000 | In situ: noninvasive; intraepithelial | IS |
| 300 | Invasion into (but not beyond) prostatic capsule Intracapsular involvement only No extracapsular extension Confined to prostate, NOS Localized, NOS | L |
| 350 | Bladder neck, microscopic invasion Extraprostatic extension (beyond prostatic capsule), unilateral, bilateral, or NOS WITHOUT invasion of the seminal vesicles Extension to periprostatic tissue WITHOUT invasion of the seminal vesicles | RE |
| 400 | Tumor invades seminal vesicle(s) | RE |
| 500 | Extraprostatic tumor that is not fixed WITHOUT invasion of adjacent structures Periprostatic extension, NOS (unknown if seminal vesicle(s) involved) Extraprostatic extension, NOS (unknown if seminal vesicle(s) involved) Through capsule, NOS | RE |
| 600 | Bladder neck, except microscopic bladder neck involvement Bladder, NOS External sphincter Extraprostatic urethra (membranous urethra) Fixation, NOS Levator muscles Rectovesical (Denonvillier's) fascia Rectum Skeletal muscle Ureter(s) | RE |
| 700 | Extension to or fixation to pelvic wall or pelvic bone "Frozen pelvis", NOS Further contiguous extension including - Other organs - Penis - Sigmoid colon - Soft tissue other than periprostatic | D |
| 800 | No evidence of primary tumor | U |
| 900 | No radical prostatectomy or autopsy performed | U |
| 950 | Radical prostatectomy performed, but not first course of treatment for example performed after disease progression | U |
| 999 | Unknown; extension not stated Unknown if radical prostatectomy done Primary tumor cannot be assessed Not documented in medical record | U |